Study Reveals MTM Value in Reducing Hospital Admission Rates

July 22, 2016

A recent study from the CVS Health Research Institute found a decline in hospital readmissions due to pharmacists’ medication therapy management (MTM) programs.

The study, An Insurers’ Care Transition Program Emphasizes Medication Reconciliation, Reduces Readmissions And Costs, was published in the July 2016 edition of Health Affairs.

The study analyzed medication reconciliation of 260 patients via pharmacist at-home visits and telephone calls. The purpose of the study was to determine whether or not medication reconciliation improved medication use, reduced hospital readmission and lowered program costs.

The study found patients who participated had a 50 percent less risk of hospital readmission. The study also saved patients $2 for every $1 spent, a combined total of $1,300 per patient. The study successfully concluded the benefits of pharmacists’ medication therapy management in reducing costs and improving patient outcomes.

“After leaving the hospital, people are especially vulnerable and are often dealing with complex and changing care regimens, which can result in high rates of medication non-adherence and increased risk for costly and unnecessary readmissions,” Troyen A. Brennan, M.D., Executive Vice President and Chief Medical Officer, CVS Health, said in a July 7 press release. “In fact, adverse drug events, often attributable to medication non-adherence, are associated with the majority of hospital readmissions. This research shows that programs that provide patients with additional support from a pharmacist can help improve health outcomes and save payers and patients money.”

Review the study.